|Bid||46.01 x 2200|
|Ask||46.02 x 1800|
|Day's range||45.99 - 46.53|
|52-week range||41.45 - 48.62|
|PE ratio (TTM)||82.49|
|Earnings date||23 Oct 2018 - 29 Oct 2018|
|Forward dividend & yield||1.56 (3.39%)|
|1y target est||50.72|
Marijuana isn’t just about getting high. Everyone from Coca-Cola Co. to pharmaceutical companies is looking to tap possible therapeutic uses of CBD, a cannabinoid found in marijuana. (Source: Bloomberg)...
September marks a decade since Lehman Brothers collapsed. After ten years, some economists are contemplating whether we’re heading towards another recession. Some analysts see a flattening yield curve as a recession indicator. Leaving aside the yield curve, macro data look encouraging. Asset prices aren’t really inflated like in 2007. However, the trade war and sanctions could depress sentiments.
The Coca-Cola Company said Monday it is "closely watching" the expanding use of a cannabis element in drinks, another sign cannabis and cannabis-infused products are getting more acceptance in mainstream culture and a harder look from long-established pillars of American business. The statement came after reports the beverage giant was in talks with a Canadian cannabis company to create a health drink infused with cannabidiol, a naturally occurring non-psychoactive compound derived from the cannabis plant. Shares of the company, Aurora Cannabis Inc., closed up nearly 17 percent on the Toronto Stock Exchange after the report.
By any conventional gauge, President Donald Trump's uncompromising stance toward tariffs and the pain they've begun to cause U.S. individuals and companies so close to midterm elections would seem politically reckless. BEIJING (AP) -- News reports quote one of China's most prominent figures in global finance as saying Beijing should pressure Washington to end their tariff battle by restricting exports of goods needed by American companies. The comments by Lou Jiwei, a former finance minister, follow reports regulators are squeezing American companies by slowing down customs approvals and stepping up inspections.
Coca-Cola may be getting into the cannabis business More from Bloomberg.comCoca-Cola Is Eyeing the Cannabis MarketChina’s Stocks Drop to Lowest Level in Nearly Four YearsChina to Cancel Talks If Trump Moves Ahead With Tariffs, Sources SayRead Coca-Cola Sets Its Sights on Cannabis on bloomberg.
Terry Booth, Aurora Cannabis Inc. chief executive officer, discusses the possibility of developing cannabis drinks with Coca-Cola Co. He speaks with Bloomberg's Amanda Lang and Shery Ahn on "Bloomberg ...
Coca-Cola says it's monitoring the cannabis drinks market and is interested in making drinks with CBD -- the non-psychoactive ingredient in marijuana that helps treat pain. Bloomberg's Emma Chandra reports ...
This marijuana stock is skyrocketing on reports that Coke wants to make a deal for developing cannabis-infused beverages.
Pot stocks Aurora Cannabis Inc. and Tilray Inc. led gains among cannabis peers Monday after Coca-Cola was said to be in discussions with the company to develop cannabidiol-infused beverages.
Aurora Cannabis Inc. led pot stocks higher after Coca-Cola Co. said it’s eyeing the cannabis drinks market, becoming the latest beverage company to tap into surging demand for marijuana products as traditional sales slow. Coca-Cola says it’s monitoring the nascent industry and is interested in drinks infused with CBD -- the non-psychoactive ingredient in marijuana that treats pain but doesn’t get you high. The Atlanta-based soft drinks maker is in talks with Canadian marijuana producer Aurora Cannabis to develop the beverages, according to a report from BNN Bloomberg Television.
Is the US-China Trade War Inevitable Now? In March, President Trump imposed a 10% tariff on US aluminum imports apparently to protect US aluminum producers from imports. In the past, Alcoa (AA) has requested President Trump address the core issue of Chinese overcapacity that’s haunting not just US producers but global aluminum producers.
The Coca-Cola Co. is moving forward with its interest in GlaxoSmithKline Plc’s Indian malted milk drink company Horlicks Ltd, according to the Sunday Telegraph.
The beverage company has entered coffee with a big splash -- we look at the coming integration of the new business.